Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

LIPOSYN 10%

SAFFLOWER OIL

Standard Dose
10% (10GM/100ML)
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview LIPOSYN 10% is listed in Drugs@FDA under application 018203 (NDA).

Marketing status: Discontinued Active ingredient SAFFLOWER OIL Form and strength INJECTABLE;INJECTION - 10% (10GM/100ML) Sponsor ABBOTT Submission history Latest submission status date: 1996-04-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview LIPOSYN 10% is listed in Drugs@FDA under application 018203 (NDA). Marketing status: Discontinued Active ingredient SAFFLOWER OIL Form and strength INJECTABLE;INJECTION - 10% (10GM/100ML) Sponsor ABBOTT Submission history Latest submission status date: 1996-04-26 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.